GWAS in cancer: progress and challenges

Mol Genet Genomics. 2020 May;295(3):537-561. doi: 10.1007/s00438-020-01647-z. Epub 2020 Feb 11.

Abstract

The genome-wide association study (GWAS) is an effective method to detect single-nucleotide polymorphisms (SNPs) of multiple individual genes based on linkage disequilibrium (LD). GWAS examines genotypes and distinguishing gene characteristics that are exhibited in diseases. In the past few decades, more and more literature has reported the results of applying GWAS to study tumors. Although many pleiotropic loci associated with complex phenotypes have been identified by GWAS, the biological functions of many genetic variation loci remain unclear, and the genetic mechanisms of most complex phenotypes cannot be systematically explained. In this article, we will review the new findings of several tumor types, and categorize the new sites and mechanisms that have recently been discovered. We linked the mechanisms of action of various tumors and searched for links to related gene expression pathways. We found that susceptible sites can be divided into hub genes and peripheral genes; the two interact to link gene expression in a variety of diseases.

Keywords: Cancer; GWAS; Genotype; Review; SNPs; Susceptible gene.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study*
  • Humans
  • Neoplasms / genetics*
  • Polymorphism, Single Nucleotide*
  • Quantitative Trait Loci*

Substances

  • Biomarkers, Tumor